Downregulation of an Evolutionary Young miR-1290 in an iPSC-Derived Neural Stem Cell Model of Autism Spectrum Disorder.
Dalia MooreBrittney M MeaysLepakshe S V MadduriFarah ShahjinSubhash ChandMeng NiuAbrar AlbahraniChittibabu GudaGurudutt PendyalaHoward S FoxSowmya V YelamanchiliPublished in: Stem cells international (2019)
The identification of several evolutionary young miRNAs, which arose in primates, raised several possibilities for the role of such miRNAs in human-specific disease processes. We previously have identified an evolutionary young miRNA, miR-1290, to be essential in neural stem cell proliferation and neuronal differentiation. Here, we show that miR-1290 is significantly downregulated during neuronal differentiation in reprogrammed induced pluripotent stem cell- (iPSC-) derived neurons obtained from idiopathic autism spectrum disorder (ASD) patients. Further, we identified that miR-1290 is actively released into extracellular vesicles. Supplementing ASD patient-derived neural stem cells (NSCs) with conditioned media from differentiated control-NSCs spiked with "artificial EVs" containing synthetic miR-1290 oligonucleotides significantly rescued differentiation deficits in ASD cell lines. Based on our earlier published study and the observations from the data presented here, we conclude that miR-1290 regulation could play a critical role during neuronal differentiation in early brain development.
Keyphrases
- cell proliferation
- autism spectrum disorder
- long non coding rna
- stem cells
- long noncoding rna
- attention deficit hyperactivity disorder
- cell cycle
- intellectual disability
- endothelial cells
- end stage renal disease
- chronic kidney disease
- spinal cord
- ejection fraction
- gene expression
- genome wide
- systematic review
- newly diagnosed
- middle aged
- electronic health record
- induced pluripotent stem cells
- blood brain barrier
- prognostic factors
- cell therapy
- multiple sclerosis
- mesenchymal stem cells
- drug induced
- deep learning
- data analysis
- meta analyses